Tissue regeneration through Gene therapy

TherageniX appoints Regenerative engineering pioneer, Prof. Cato Laurencin to its Scientific Advisory Board

Biomaterials, stem cells and gene therapy expert, and orthopaedic surgeon joins TherageniX’s scientific Advisory Board to advance product development and advise on company strategy. TherageniX (www.theragenix.health) , an early-stage biotechnology company pioneering the use of gene therapy for tissue regeneration announced that it has appointed Prof. Cato Laurencin to its Scientific Advisory Board.  Dr. Cato […]

TherageniX appoints Professor Ben Ollivere to its Scientific Advisory Board

Experienced Orthopaedic surgeon, researcher, and academic joins TherageniX’s scientific Advisory Board to help accelerate product development. TherageniX (www.theragenix.health) , an early-stage biotechnology company pioneering the use of gene therapy for tissue regeneration announced that it has appointed Prof. Ben Ollivere from the University of Nottingham to its Scientific Advisory Board. Professor Ollivere works at the […]

TherageniX is looking for a Scientific Project Manager

Job Title  Scientific Project Manager Job Type  Fixed-Term 1 year (with possibility of extension), Full-time Hours per week  37.5 per week Location  Remote with occasional travel within the UK  Pay  £45,000 – £50,000 per annum plus benefits Start Date  January 2024 About Us  TherageniX is an early-stage biotechnology company focused on using a gene therapy […]

TherageniX and University of Nottingham Awarded £995K Innovate UK Grant to Develop Powdered Gene Therapy for Bone Regeneration

London, UK, and Nottingham, UK, 31 August 2023: TherageniX, a University of Nottingham spin out pioneering a dry powder gene therapy formulation for bone graft augmentation, and its collaborator, the University of Nottingham, have been awarded a £995,000 grant from Innovate UK, the UK’s innovation agency. The funding will support the development of the Company’s […]

THERAGENIX: SPIN-OUT COMPANY ESTABLISHED TO PROVIDE GENE THERAPY IN BONE REPAIR SURGERY

Our partner, U of N also shared their perspective on the launch of TherageniX, a spin-out company – TherageniX to deliver gene therapy as part of bone repair surgery. The innovative approach aims to enhance the healing process by introducing genes that promote bone regeneration. TherageniX establishment signifies a significant step towards translating research findings into practical applications, […]

INTRODUCING THERAGENIX: TISSUE REGENERATION THROUGH GENES

Disease, injuries and aging can damage body tissues. There is an unmet need for novel therapies to enable tissue repair and regeneration. The use of gene therapy to provide biological cues to boost the body’s response has been shown to aid regeneration of skin, bone, muscle and cartilage. TherageniX, another venture from NLC, delivers genes […]